Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions

Molecular Endocrinology

Volumn 13, Issue 8, 1999, Pages 1373-1387

  Wang, W ^a   Dong, L ^a   Saville, B ^a   Safe, S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; ESTRADIOL; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ESTROGEN ACTIVITY; GENE DELETION; GENE SEQUENCE; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION;

EID: 0033305456     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.8.0323     Document Type: Article

References (58)

1. Introduction to the E2F family: Protein structure and gene regulation
2. In vivo association of E2F and DP family proteins
3. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1
4. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
5. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation
6. Transcriptional control by E2F
7. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members
8. Cell cycle regulation of E2F site occupation in vivo
9. Regulatory interactions among E2Fs and cell cycle control proteins
10. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo
11. Constitutive protection of E2F recognition sequences in the human thymidine kinase promoter during cell cycle progression
12. G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter
13. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis
14. p53 and E2F-1 cooperate to mediate apoptosis
15. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53
16. Induction of DNA synthesis and apoptosis are separable functions of E2F-1
17. E2F-1 functions in mice to promote apoptosis and suppress proliferation
18. Tumor induction and tissue atrophy in mice lacking E2F-1
19. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: Modulation of hormone-induced cell cycle enzymes
20. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells
21. 1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2
22. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution
23. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression
24. 1 phase of the cell cycle
25. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle
26. 1 phase
27. Mammalian G1 cyclins
28. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells
29. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation
30. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells
31. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members
32. The cell cycle and the retinoblastoma protein family
33. Functional synergy between the transcription factor Sp1 and the estrogen receptor
34. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
35. Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes
36. Estrogen-induced retinoic acid receptor α1 gene expression: Role of estrogen receptor-Sp1 complex
37. 2
38. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells
39. Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes
40. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression
41. E2F-mediated growth regulation requires transcription factor cooperation
42. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
43. Cooperative binding of NF-Y and Sp1 at the DNase I-hypersensitive site, fatty acid synthase insulin-responsive element 1, located at -500 in the rat fatty acid synthase promoter
44. Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y
45. Dominant negative analogs of NF-YA
46. HTLV-1 Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization
47. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene
48. CDK-independent activation of estrogen receptor by cyclin D1
49. A survey of 178 NF-Y binding CCAAT boxes
50. CCAAT-enhancer-binding proteins (C/EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins
51. Promoter of the Na, K-ATPase α3 subunit gene is composed of cis elements to which NF-Y and Sp1/Sp3 bind in rat cardiocytes
52. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
53. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
54. Hormone-induced recruitment of Sp1 mediates estrogen activation of the rabbit uteroglobin gene in endometrial epithelium
55. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
56. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells
57. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression
58. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300